After early observations that adrenal chromaffin cells transplanted in rats can survive in the host brain, clinical trials were initiated in humans. The early results, encouraging to some extent, were questioned later, especially due to poor graft survival. One of the proposed explanations was the contamination of adrenal grafts with nonchromaffin cells. When this was corrected, improved survival and graft function
Was this article helpful?